The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema

Thorbjørn Hermanrud, Nicolaj Duus, Anette Bygum, Eva Rye Rasmussen

Research output: Contribution to journalJournal articleResearchpeer-review

148 Downloads (Pure)

Abstract

Angioedema of the upper airways is a severe and potentially life-threatening condition. The incidence has been increasing in the past two decades, primarily due to pharmaceuticals influencing the generation or degradation of the vasoactive molecule bradykinin. Plasma-derived C1-esterase inhibitor concentrate is a well-established treatment option of hereditary and acquired complement C1-esterase inhibitor deficiency, which are also mediated by an increased level of bradykinin resulting in recurrent angioedema. We here present a case of severe angiotensin converting enzyme-inhibitor related angioedema (ACEi-AE) of the hypopharynx that completely resolved rapidly after the infusion of plasma-derived C1-inhibitor concentrate adding to the sparse reports in the existing literature.

Original languageEnglish
Article number3930923
JournalCase Reports in Emergency Medicine
Volume2016
Number of pages4
ISSN2090-648X
DOIs
Publication statusPublished - 2016

Fingerprint Dive into the research topics of 'The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema'. Together they form a unique fingerprint.

  • Cite this